Prescription drugs Tariffs Donald Trump See all topics Facebook Tweet Email Link Link Copied! Follow

Ever since President Donald Trump started promising to slap tariffs on pharmaceutical imports, drugmakers have unveiled a flurry of commitments to build or expand US manufacturing operations in the coming years.

AstraZeneca is investing $50 billion to expand its drug manufacturing in the US. Johnson & Johnson is pouring $55 billion into domestic production and research. And Eli Lilly said it will spend $27 billion to build four new manufacturing plants here.

In total, the planned investments exceed $250 billion, according to two industry analysts.

Trump is wielding the threat of tariffs to get drugmakers to increase their domestic production, whi

See Full Page